GREM2 was identified as one of the factors involved in malignant transformation of meningiomas by bioinformatics analysis [16], but the mechanism of GREM2 expression leading to suppression of BMP, the transforming growth factor-β signaling pathway, and tumor progression, was unclear. The gene discussed is GREM2; the disease is neoplasm.